Form 4: Know Labs Insider Erickson Extends Warrants, Maintaining Significant Beneficial Ownership
SEC Form 4 Filing
Ronald P. Erickson, a director, officer, and chairman of Know Labs, Inc., filed a Form 4 indicating an extension of warrant expiration dates, maintaining a substantial stake in the company.
Summary
- Ronald P. Erickson, a director, officer, and chairman of Know Labs, Inc., reported changes in beneficial ownership via a Form 4 filing with the SEC.
- The filing primarily concerns the extension of the expiration dates for two warrant tranches to purchase common stock, initially exercisable from January 31, 2018.
- The warrant exercise term is amended such that the term of the warrant will be extended for an additional two (2) year period, and the Warrants shall now expire on 01/31/2026.
- Erickson directly and indirectly holds a significant amount of common stock (1,488,085 shares directly), convertible debentures (convertible into 4,736,264 shares indirectly), warrants (3,894,666 shares directly and indirectly), and options (7,931,350 shares directly).
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing is a routine disclosure of insider activity (warrant extension) and doesn't inherently indicate positive or negative news about the company's performance.
Positives
- The extension of the warrants demonstrates Erickson's continued commitment to Know Labs.
- Erickson's significant holdings of common stock, convertible debentures, warrants, and options align his interests with those of other shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The extension of warrants is a fairly common practice, often used to incentivize key personnel or investors.
Stakeholder Impact
- The warrant extension could be viewed positively by shareholders as it signals continued commitment from a key insider.
- The extension does not have an immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/31/2018 | Initial exercisable date of warrants being extended. |
| 11/04/2019 | Date of option grant with exercise price of $1.10. |
| 12/15/2020 | Date of option and warrant grants with exercise price of $1.53. |
| 12/16/2021 | Date of option grant with exercise price of $2.09. |
| 12/14/2022 | Date of option grant with exercise price of $1.41. |
| 10/10/2023 | Date of option grant with exercise price of $0.25. |
| 01/30/2024 | Date of Warrant Extension Agreement. |
| 01/31/2026 | New expiration date for extended warrants. |
| 05/31/2024 | Date of Form 4 filing. |
Keywords
Form 4, beneficial ownership, warrant extension, Know Labs, KNW, Erickson, convertible debentures, stock options, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.